```html

Myelitis: A Complete Medical Guide

Overview

Myelitis is an umbrella term for inflammation of the spinal cord. The condition can result from infections, autoimmune reactions, or post‑viral immune responses. Inflammation damages the protective myelin sheath that surrounds spinal cord nerve fibers, disrupting the transmission of signals between the brain and the rest of the body.

Who it affects: Myelitis can occur at any age, but certain subtypes have characteristic demographics:

• Acute disseminated encephalomyelitis (ADEM) – most common in children < 15 years.
• Transverse myelitis – peaks in adults 30‑50 years; slight female predominance.
• Neuromyelitis optica spectrum disorder (NMOSD) – more frequent in women (≈ 80 %).

Prevalence: Exact numbers are difficult because myelitis is rare and often under‑diagnosed. Estimates from the U.S. National Institute of Neurological Disorders and Stroke (NINDS) suggest an incidence of 1–8 cases per million per year for transverse myelitis, and about 0.5 per 100,000 for NMOSD worldwide.<sup>[1] CDC, 2023</sup>

Symptoms

Symptoms develop suddenly (hours to days) or over several weeks, depending on the underlying cause. They typically follow a “level” on the spinal cord – meaning that everything below that level is affected.

Neurologic symptoms

• Motor weakness – often symmetric, ranging from mild clumsiness to complete paraplegia.
• Sensory loss – numbness, tingling, or a “pins‑and‑needles” sensation that spreads from the torso outward.
• Spasticity – involuntary muscle stiffness or spasms.
• Loss of reflexes (early) or hyper‑reflexia (later).
• Pain – sharp, burning, or aching pain at the level of inflammation; may radiate to the limbs.
• Bladder and bowel dysfunction – urgency, incontinence, or retention.
• Sphincter control loss – difficulty controlling gas or feces.
• Autonomic dysregulation – irregular heart rate or blood pressure swings.

Systemic symptoms (when infection‑related)

• Fever, chills, or flu‑like malaise.
• Headache or neck stiffness (suggesting meningitis).
• Rash or recent exposure to ticks, mosquitoes, or other vectors.

Causes and Risk Factors

Infectious triggers

• Viral: HSV‑1/2, VZV, EBV, CMV, Enteroviruses, West Nile, COVID‑19.
• Bacterial: Mycoplasma pneumoniae, Borrelia burgdorferi (Lyme disease).
• Parasitic and fungal infections (rare).

Autoimmune and inflammatory disorders

• Multiple sclerosis (MS) – demyelinating lesions can involve the spinal cord.
• Neuromyelitis optica spectrum disorder (NMOSD) – antibodies against aquaporin‑4.
• Systemic lupus erythematosus, Sjögren’s syndrome, sarcoidosis.

Post‑infectious or post‑vaccination immune response

Often termed “post‑infectious transverse myelitis,” it appears 1‑4 weeks after a viral illness or, rarely, after immunizations (e.g., influenza, COVID‑19). The immune system mistakenly attacks spinal cord tissue.

Other risk factors

• Age: children for ADEM; adults for transverse myelitis.
• Female sex (especially for NMOSD).
• Pre‑existing autoimmune disease.
• Genetic predisposition – certain HLA alleles have been linked to increased susceptibility.

Diagnosis

Because myelitis mimics many neurologic conditions, a systematic approach is essential.

Clinical evaluation

1. Detailed history – symptom onset, recent infections, vaccinations, autoimmune disease, travel.
2. Comprehensive neurologic exam – determines the spinal level involved.

Imaging studies

• MRI of the spine (with and without gadolinium) – gold standard; shows hyperintense T2 lesions, cord swelling, and contrast enhancement.
• Brain MRI – assesses for concurrent demyelinating lesions (suggestive of MS or NMOSD).

Laboratory tests

• CSF analysis (lumbar puncture) – elevated protein, mild pleocytosis, oligoclonal bands (MS) or AQP4 antibodies (NMOSD).
• Serum autoimmune panel – ANA, anti‑dsDNA, SSA/SSB, AQP4‑IgG, MOG‑IgG.
• Infectious work‑up – PCR for viruses (HSV, VZV), Lyme serology, COVID‑19 testing.
• Basic labs – CBC, metabolic panel, vitamin B12 (deficiency can mimic myelitis).

Electrodiagnostic studies

Somatosensory evoked potentials (SSEPs) may help confirm conduction block when MRI is inconclusive.

Treatment Options

Treatment is time‑critical; early intervention improves recovery chances.

Acute management

• High‑dose intravenous corticosteroids – methylprednisolone 1 g/day for 3‑5 days (most common first‑line). Reduces inflammation and edema.
• Plasma exchange (PLEX) – considered if no improvement after steroids or for NMOSD/ADEM.
• Intravenous immunoglobulin (IVIG) – alternative for steroid‑refractory cases, especially when infection is suspected.

Targeted therapy for specific causes

• Antiviral agents (e.g., acyclovir for HSV/VZV).<sup>[2] Mayo Clinic, 2022</sup>
• Antibiotics for bacterial etiologies (e.g., doxycycline for Lyme disease).
• Immunosuppressants for NMOSD – rituximab, mycophenolate mofetil, or eculizumab.
• Disease‑modifying therapies for MS‑related myelitis.

Supportive and rehabilitation measures

• Bladder/bowel training, catheterization if needed.
• Physical therapy – range of motion, gait training, strength conditioning.
• Occupational therapy – adaptive equipment for daily living.
• Pain management – neuropathic agents (gabapentin, pregabalin) and NSAIDs.

Lifestyle and long‑term strategies

• Vaccinations (influenza, COVID‑19, shingles) – reduce infection triggers.
• Regular follow‑up with a neurologist to monitor for relapses.
• Healthy diet rich in omega‑3 fatty acids and antioxidants may support neuro‑recovery.

Living with Myelitis

Adjusting to life after an acute episode involves physical, emotional, and practical steps.

Daily management tips

1. Establish a routine—consistent sleep, medication times, and therapy sessions promote stability.
2. Use assistive devices early—canes, walkers, or wheelchair cushions prevent falls and fatigue.
3. Skin care—inspect areas of reduced sensation daily to avoid pressure ulcers.
4. Bladder diary—track volume and frequency to guide urologist recommendations.
5. Stay active within limits—gentle stretching and low‑impact aerobic exercise improve circulation and mood.

Psychosocial support

• Join support groups (e.g., NMOSD Foundation, MS Society).
• Consider counseling or cognitive behavioral therapy for anxiety/depression, which affect up to 30 % of patients.<sup>[3] Cleveland Clinic, 2021</sup>

Employment and accessibility

• Communicate with employers about needed accommodations (flexible hours, ergonomic workstation).
• Utilize disability resources when functional impairment is significant.

Prevention

Because many cases are triggered by infections or autoimmune activity, prevention focuses on reducing those risks.

• Vaccination – stay up‑to‑date with influenza, COVID‑19, shingles, and pneumococcal vaccines.
• Prompt infection treatment – seek medical care for fever, rash, or neurological symptoms early.
• Tick‑bite precautions – wear long sleeves, use repellents, and perform thorough skin checks after outdoor activities.
• Maintain a healthy immune system – balanced diet, regular exercise, adequate sleep, and stress management.
• Screen for autoimmune disease if you have a family history; early treatment may lower the chance of spinal involvement.

Complications

When myelitis is not promptly treated, or when severe inflammation occurs, several complications can arise:

• Permanent motor deficit – residual weakness or paralysis.
• Chronic pain – neuropathic pain persisting months to years.
• Neurogenic bladder – requiring lifelong catheterization or surgical reconstruction.
• Spasticity and contractures – may need orthopedic interventions.
• Secondary infections – skin breakdown, urinary tract infections.
• Psychiatric sequelae – depression, anxiety, social isolation.
• Relapse or progression – especially in NMOSD or MS‑related myelitis.

When to Seek Emergency Care

Early emergency treatment can dramatically improve outcomes and reduce the risk of long‑term disability.

---

Sources: [1] Centers for Disease Control and Prevention (CDC). “Acute Disseminated Encephalomyelitis (ADEM).” 2023. [2] Mayo Clinic. “Myelitis: Symptoms, Causes & Treatment.” Updated 2022. [3] Cleveland Clinic. “Depression and Anxiety in Neurological Disorders.” 2021. National Institute of Neurological Disorders and Stroke (NINDS). “Transverse Myelitis Fact Sheet.” 2022. World Health Organization (WHO). “Guidelines for Diagnosis and Treatment of Neuromyelitis Optica.” 2020.

```